O'Shaughnessy C T, Connor H E
Department of Neuropharmacology, Glaxo Group Research, Ware, Herts., UK.
Eur J Pharmacol. 1993 May 19;236(2):319-21. doi: 10.1016/0014-2999(93)90605-h.
Selective neurokinin receptor agonists and calcitonin gene-related peptide (CGRP) were administered i.v. to anaesthetised guinea-pigs, and plasma protein extravasation was measured in dura and conjunctiva, intra- and extracranial tissues, respectively, innervated by the trigeminal nerve. The neurokinin NK1 receptor agonist, GR73632 enhanced plasma protein extravasation in guinea-pig dura (10 nmol/kg i.v.) and conjunctiva (3 and 10 nmol/kg i.v.). Pretreatment with the neurokinin NK1 receptor antagonist GR82334 (200 nmol/kg i.v.) blocked the response to GR73632 in both tissues. Neurokinin NK2 and NK3 receptor-selective agonists, GR64349 (10 nmol/kg i.v.) and senktide (30 nmol/kg i.v.) respectively, and also the neuropeptide CGRP (10 nmol/kg i.v.) had no significant effect on plasma protein extravasation in intra- or extracranial tissues. We conclude that the neurokinin NK1 receptor mediates plasma protein extravasation in tissues innervated by the trigeminal nerve in guinea-pigs; neurokinin NK2, NK3 and CGRP receptors do not directly mediate extravasation of plasma proteins in these tissues.
将选择性神经激肽受体激动剂和降钙素基因相关肽(CGRP)静脉注射给麻醉的豚鼠,并分别在由三叉神经支配的硬脑膜和结膜、颅内和颅外组织中测量血浆蛋白外渗。神经激肽NK1受体激动剂GR73632(静脉注射10 nmol/kg)可增强豚鼠硬脑膜(静脉注射10 nmol/kg)和结膜(静脉注射3和10 nmol/kg)中的血浆蛋白外渗。用神经激肽NK1受体拮抗剂GR82334(静脉注射200 nmol/kg)预处理可阻断两种组织中对GR73632的反应。神经激肽NK2和NK3受体选择性激动剂GR64349(静脉注射10 nmol/kg)和senktide(静脉注射30 nmol/kg)以及神经肽CGRP(静脉注射10 nmol/kg)对颅内或颅外组织中的血浆蛋白外渗均无显著影响。我们得出结论,神经激肽NK1受体介导豚鼠三叉神经支配组织中的血浆蛋白外渗;神经激肽NK2、NK3和CGRP受体不直接介导这些组织中血浆蛋白的外渗。